| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $83K | -22.9% | +171.5% |
| R&D Expense | $134K | -18.6% | -22.0% |
| SG&A Expense | $550K | -5.0% | +28.3% |
| Operating Income | -$684K | +8.2% | +0.5% |
| Net Income | -$678K | +7.4% | -2.2% |
| EPS (Basic) | -$0.15 | +6.3% | +6.3% |
| EPS (Diluted) | -$0.15 | +6.3% | +6.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $641K | -45.0% | -77.6% |
| Accounts Receivable | $19K | +163.7% | +327.4% |
| Current Assets | $822K | -38.3% | -73.8% |
| Total Assets | $1.5M | -25.3% | -60.8% |
| Current Liabilities | $190K | -61.2% | -9.9% |
| Stockholders' Equity | $1.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.5M | — | — |
| Investing Cash Flow | -$207K | — | — |
| Financing Cash Flow | $3.1M | — | — |
| -63.8% |